Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Submitted by
admin
on April 6, 2018 - 9:51am
Source:
Marketwatch
News Tags:
Incyte
Merck
melanoma
epacadostat
Keytruda
clinical trials
metastatic melanoma
Headline:
Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment
Do Not Allow Advertisers to Use My Personal information
